Filing Flows

Filing Flows › Companies › Microbot Medical › Cash flow

Microbot Medical cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$5.1M in Q2 2026 · −$17.9M over twelve months

Operating cash flow−$5.0M
Capital spending−$142K
Free cash flow−$5.1M
Cash conversion cycle218 days

Analysis

In Q2 2026, Microbot Medical generated −$5.0M of operating cash flow and spent $142K on capital projects, leaving free cash flow of −$5.1M. That is $2.5M less than in Q2 2025 (−$2.6M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$17.6M; the largest uses were other investing ($36.5M), operating cash flow ($17.6M), capital spending ($288K); besides operations, cash came from shares issued ($53.7M), other financing ($1K); the cash balance fell by $720K.

Operating cash flow was −$5.0M against net income of −$5.6M. The largest differences: inventory −$650K, stock-based pay +$433K, receivables −$71K.

Its cash conversion cycle was 218 days (receivables 53 + inventory 266 − payables 101).

Free cash flow

Microbot Medical: free cash flow by quarterMicrobot Medical: free cash flow by quarter−$2.8MQ3 2024−$1.7MQ4 2024−$2.9MQ1 2025−$2.6MQ2 2025−$3.9MQ3 2025−$3.8MQ4 2025−$5.2MQ1 2026−$5.1MQ2 2026
Operating cash flow less capital spending.
Microbot Medical: operating cash flow against capital spendingMicrobot Medical: operating cash flow against capital spendingOperating cash flowCapital spending−$2.8M$0Q3 2024−$1.7M$7KQ4 2024−$2.9M$13KQ1 2025−$2.6M$9KQ2 2025−$3.8M$13KQ3 2025−$3.8M$25KQ4 2025−$5.1M$108KQ1 2026−$5.0M$142KQ2 2026
Latest (Q2 2026): Operating cash flow −$5.0M, Capital spending $142K.

Capital allocation, year by year

Microbot Medical: where the cash came from (up) and went (down), by fiscal yearMicrobot Medical: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2021: Operating cash flow −$9.4MFY2021: Net borrowing −$16KFY2021: Capital spending −$69KFY2021FY2022: Operating cash flow −$11.5MFY2022: Net borrowing −$16KFY2022: Shares issued $4.3MFY2022: Capital spending −$84K$4.3MFY2022FY2023: Operating cash flow −$8.5MFY2023: Net borrowing −$16KFY2023: Shares issued $6.6MFY2023: Capital spending −$33K$6.6MFY2023FY2024: Operating cash flow −$8.8MFY2024: Net borrowing −$16KFY2024: Shares issued $7.9MFY2024: Capital spending −$25K$7.9MFY2024FY2025: Operating cash flow −$13.0MFY2025: Shares issued $86.2MFY2025: Capital spending −$60K$86.2MFY2025
Over these 5 years operating cash flow totalled −$51.3M; the largest uses were operating cash flow ($51.3M) and capital spending ($271K). Cash-flow statements as filed.

Where the cash came from and went

Microbot Medical: sources (+) and uses (−) of cash, Q2 2026Microbot Medical: sources (+) and uses (−) of cash, Q2 2026Operating cash flow−$5.0MOther investing$4.6MCash drawn (+) / kept (−)$502KCapital spending−$142KNot reconciled$16K
Microbot Medical: sources (+) and uses (−) of cash, TTM to Q2 2026Microbot Medical: sources (+) and uses (−) of cash, TTM to Q2 2026Shares issued$53.7MOther investing−$36.5MOperating cash flow−$17.6MCash drawn (+) / kept (−)$720KCapital spending−$288KOther financing$1K

From profit to cash

Microbot Medical: net income to operating cash flow, Q2 2026Microbot Medical: net income to operating cash flow, Q2 2026Net income−$5.6MDepreciation & amortization$15KStock-based pay$433KReceivables−$71KInventory−$650KOperating cash flow−$5.0M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$5.0M−$142K—$502K−$5.1M
Q1 2026−$5.1M−$108K—$56K−$5.2M
Q4 2025−$3.8M−$25K—$2.8M−$3.8M
Q3 2025−$3.8M−$13K—−$2.6M−$3.9M
Q2 2025−$2.6M−$9K$4.8M−$870K−$2.6M
Q1 2025−$2.9M−$13K$27.8M−$102K−$2.9M
Q4 2024−$1.7M−$7K$2.8M−$2.6M−$1.7M
Q3 2024−$2.8M—$633K$2.0M−$2.8M

Microbot Medical: income statement and cash flow

Microbot Medical, Q2 2026: revenue $241K. The chart follows the revenue to costs, profit and cash.

Microbot Medical: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.